Anixa Biosciences Inc (ANIX) stock
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
$2.44−0.16 (-6.15%)
Close on Nov 20, 2026Market cap $84.82MP/E –Yield –
Anixa Biosciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2012 it was $936.14K, down 3.4% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2012 | Oct 31, 2012 | $936.14K | -3.4% |
| FY2011 | Oct 31, 2011 | $969.11K | +49.5% |
| FY2010 | Oct 31, 2010 | $648.37K | – |
See a number that looks wrong?